Search Results

Editorial [Hot topic: Pharmacogenetics: Current Status and Future Perspectives (Executive Editor: Henk-Jan Guchelaar)]

Author: Guchelaar, Henk-Jan

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 135-135(1)

Publisher: Bentham Science Publishers

Pharmacogenetics in Psychiatry - A Useful Clinical Tool or Wishful Thinking for the Future?

Authors: Kirchheiner, J.; Seeringer, A.; Viviani, R.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 136-144(9)

Publisher: Bentham Science Publishers

Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease

Authors: Derijks, L. J.J.; Wong, D. R.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 145-154(10)

Publisher: Bentham Science Publishers

Pharmacogenetics in Oncology: A Promising Field

Authors: Houtsma, D.; Guchelaar, H. J.; Gelderblom, H.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 155-163(9)

Publisher: Bentham Science Publishers

Pharmacogenetics in Treatment of Rheumatoid Arthritis

Authors: Kooloos, W. M.; Huizinga, T. W.J.; Guchelaar, H.-J.; Wessels, J. A.M.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 164-175(12)

Publisher: Bentham Science Publishers

Individualizing Calcineurin Inhibitor Therapy in Renal Transplantation - Current Limitations and Perspectives

Authors: Press, R. R.; de Fijter, J. W.; Guchelaar, H.-J.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 176-186(11)

Publisher: Bentham Science Publishers

Pharmacogenetics of Oral Anticoagulant Therapy

Authors: Schalekamp, T.; de Boer, A.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 187-203(17)

Publisher: Bentham Science Publishers

Pharmacogenetics of Phase I and Phase II Drug Metabolism

Authors: Crettol, Severine; Petrovic, Nenad; Murray, Michael

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 204-219(16)

Publisher: Bentham Science Publishers

Pharmacogenetics of Drug Transporters

Authors: Franke, R. M.; Gardner, E. R.; Sparreboom, A.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 220-230(11)

Publisher: Bentham Science Publishers

Pharmacogenetics and the Pharmaceutical Industry

Authors: Raaijmakers, Jan. A.M.; Koster, Ellen S.; der Zee, Anke-Hilse M.a.i.t.l.a.n.d-v.a.n.

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 238-244(7)

Publisher: Bentham Science Publishers

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy

Authors: FERDER, N. S.; EBY, C. S.; DEYCH, E.; HARRIS, J. K.; RIDKER, P. M.; MILLIGAN, P. E.; GOLDHABER, S. Z.; KING, C. R.; GIRI, T.; MCLEOD, H. L.; GLYNN, R. J.; GAGE, B. F.

Source: Journal of Thrombosis and Haemostasis, Volume 8, Number 1, January 2010 , pp. 95-100(6)

Publisher: Blackwell Publishing

Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine

Authors: Paci, D.; Ibarreta, D.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 284-296(13)

Publisher: Bentham Science Publishers

Personalized and Predictive Medicine in Turkey: A Symposium Report of the Istanbul Working Group on Personalized Medicine, Istanbul, Turkey, September 10-12, 2009

Authors: Hyzel, C.; Gok, S.; Sardas, S.; Bernard-Gallon, D.; Maugard, C.; Genc, E.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 297-301(5)

Publisher: Bentham Science Publishers

Workshop at WorldPharma2010, Copenhagen, Denmark: “Implementation and Obstacles of Pharmacogenetics in Clinical Practice”, July 20, 2010

Author: Cascorbi, I.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 302-302(1)

Publisher: Bentham Science Publishers

Genetic predictors of toxicities to chemotherapy

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 3-3(1)

Publisher: Adis International

Iloperidone: a new option for the treatment of schizophrenia

Author: Cutler, Andrew J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 12, December 2009 , pp. 1727-1741(15)

Publisher: Expert Reviews

Drug Focus: Pharmacogenetic studies related to cyclophosphamide-based therapy

Authors: Pinto, Navin; Ludeman, Susan M; Dolan, M Eileen

Source: Pharmacogenomics, Volume 10, Number 12, December 2009 , pp. 1897-1903(7)

Publisher: Future Medicine

Genetic determinants of warfarin dosing in the Han-Chinese population

Authors: Lee, MT Michael; Chen, Chien-Hsiun; Chou, Ching-Heng; Lu, Liang-Suei; Chuang, Hui-Ping; Chen, Ying-Ting; Saleem, Amir N; Wen, Ming-Shien; Chen, Jin-Jer; Wu, Jer-Yuarn; Chen, Yuan-Tsong

Source: Pharmacogenomics, Volume 10, Number 12, December 2009 , pp. 1905-1913(9)

Publisher: Future Medicine

10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal

Authors: Kurnik, Daniel; Loebstein, Ronen; Halkin, Hillel; Gak, Eva; Almog, Shlomo

Source: Pharmacogenomics, Volume 10, Number 12, December 2009 , pp. 1955-1965(11)

Publisher: Future Medicine

Development of an undergraduate pharmacogenomics curriculum

Authors: O'Brien, Travis J; Goodsaid, Federico; Plack, Margaret; Harralson, Arthur; Harrouk, Wafa; Hales, Tim G; Mandel, H George; Perry, David C; Kennedy, Katherine; Sarvazyan, Narine; Chiappinelli, Vincent A

Source: Pharmacogenomics, Volume 10, Number 12, December 2009 , pp. 1979-1986(8)

Publisher: Future Medicine